Developing imaging technologies for therapeutic interventions in rare diseases (BIOIMAGE-NMD)
Research Areas
At a Glance
- Status: Active Consortium
- Year Launched: 2013
- Initiating Organization: European Commission Seventh Framework Programme (FP7)
- Initiator Type: Government
- Rare disease
- Disease focus:
Muscular Dystrophy - Location: Europe
Abstract
The overarching objective of the BIOIMAGE-NMD project is to deliver combined structural and molecular imaging biomarkers with proven utility for the detection of therapeutic effects in patients with rare neuromuscular diseases (NMDs).
Mission
The project will have three specific objectives:
Financing
Funding is provided by the Seventh Framework Programme of the European Union.
Other website |
http://www.treat-nmd.eu/about/related-projects/bioimage-nmd/ |
Sponsors & Partners
CRIS |
Institute of Myology Paris |
Leids Universitair Medisch Centrum |
Newcastle University |
Prosensa Therapeutics |
SCITO |
Universita Cattolica del Sacro Cuore of Milan |
University College London |
University Hospitals Leuven |